Method for preparing tetanus toxin recombinant antigen and its use
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NAT INST FOR THE CONTROL OF PHARMA & BIOLOGICAL PROD
- Publication Date
- 2005-07-20
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of genetic engineering, and in particular relates to a recombinant vector containing a tetanus toxin antigen gene, a host transformed with the vector and a transformant used to produce the tetanus toxin antigen, and the antigen in a tetanus vaccine and a combination vaccine protein carrier in the application. technical background
[0002] Tetanus is caused by the infection of Clostridium tetani (Clostridium tetani). Under anaerobic conditions, bacteria produce a large amount of toxin-tetanus neurotoxin (abbreviated as tetanus toxin). Sexual muscle tonic spasm, severe cases finally died of suffocation and systemic failure. It is generally estimated that about 1 million people die from tetanus each year, about 80% of whom are newborns. Due to its sinister symptoms, high morbidity and mortality, tetanus has been highly valued by the medical profession. The most effective way to control tetanus is to vaccinat...